By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Expression Analysis announced yesterday that it has teamed up with Illumina and Golden Helix on an RNA-Seq grant program.

Under the program, Expression Analysis will perform the sequencing and provide primary and secondary data analysis, while Golden Helix will provide cloud-based secondary analysis tools and storage as well as end-user tertiary analysis tools. Illumina will provide the products for the studies, Expression Analysis said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.